Technical Analysis for VNRX - VolitionRX Limited

Grade Last Price % Change Price Change
grade B 3.23 -3.00% -0.10
VNRX closed down 3.0 percent on Friday, May 24, 2019, on 26 percent of normal volume. The stock fell below its 50 day moving average, damaging its intermediate-term outlook by crossing under that important trendline.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Up Down Down
See historical VNRX trend table...

Date Alert Name Type % Chg
Fell Below 50 DMA Bearish 0.00%
Bollinger Band Squeeze Range Contraction 0.00%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup -3.00%
Pocket Pivot Bullish Swing Setup -3.00%
Bollinger Band Squeeze Range Contraction -3.00%
Inside Day Range Contraction -3.00%
50 DMA Support Bullish -1.52%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup -1.52%
Bollinger Band Squeeze Range Contraction -1.52%
20 DMA Resistance Bearish -3.29%

Older signals for VNRX ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
VolitionRX Limited, a development stage life sciences company, focuses on developing cancer detection blood tests for detecting and diagnosing cancer and other diseases. It develops two blood tests in the NuQ-X family to detect the presence of cancer by detecting nucleosomes containing specific nucleotides; and three blood tests in the NuQ-V family to detect cancer and nucleosomes containing specific histone variants. The company also develops nine blood tests in the NuQ-M family to detect cancer by detecting nucleosomes containing modified histones, the proteins that package, and order DNA into nucleosomes; and five blood tests in the NuQ-A family to detect cancer by detecting nucleosome-protein adducts, as well as offers research kits. It develops HyperGenomics tissue and blood-based tests to determine disease subtype following initial diagnosis and to help appropriate therapy; NuQ Endo endometriosis test; and NuQ clinical diagnostic products. VolitionRX Limited is based in Singapore.
Cancer Biology Diseases Disease Molecular Biology
Is VNRX a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 2 bullish, 1 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 3.625
52 Week Low 1.44
Average Volume 71,458
200-Day Moving Average 2.6375
50-Day Moving Average 3.2661
20-Day Moving Average 3.3593
10-Day Moving Average 3.3325
Average True Range 0.1319
ADX 21.36
+DI 11.492
-DI 25.5998
Chandelier Exit (Long, 3 ATRs ) 3.2293
Chandelier Exit (Short, 3 ATRs ) 3.5557
Upper Bollinger Band 3.5592
Lower Bollinger Band 3.1594
Percent B (%b) 0.18
BandWidth 11.901289
MACD Line 0.0006
MACD Signal Line 0.0196
MACD Histogram -0.019
Fundamentals Value
Market Cap 85.65 Million
Num Shares 26.5 Million
EPS -0.52
Price-to-Earnings (P/E) Ratio -6.21
Price-to-Sales 0.00
Price-to-Book 3.88
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 3.43
Resistance 3 (R3) 3.44 3.40 3.39
Resistance 2 (R2) 3.40 3.35 3.39 3.38
Resistance 1 (R1) 3.31 3.32 3.29 3.30 3.37
Pivot Point 3.27 3.27 3.26 3.26 3.27
Support 1 (S1) 3.18 3.22 3.16 3.17 3.09
Support 2 (S2) 3.14 3.19 3.13 3.08
Support 3 (S3) 3.05 3.14 3.07
Support 4 (S4) 3.04